Batimastat (mnemonic: batty-mustard) (INN/USAN, codenamed BB-94) is a drug that was invented by Laurie Hines of British Biotech (now Vernalis).

Dan Lednicer wrote about this compound in book #6 of his organic drug synthesis series.

The drug reached Phase III but was never marketed; mainly because it couldn't be administered orally (as opposed to the newer and chemically similar MMPI marimastat), and injection into the peritoneum caused peritonitis.

[1] It is well-known that other methods of administration include transdermal (skin lotion) as well as rectal suppositories.

[citation needed] This article incorporates public domain material from Dictionary of Cancer Terms.